These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 11064947

  • 1. The role of the liver on post-prandial glycaemia--emphasis on hepatic glucose uptake.
    Kawamori R.
    Int J Clin Pract Suppl; 2000 Sep; (112):19-22. PubMed ID: 11064947
    [No Abstract] [Full Text] [Related]

  • 2. The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes.
    Gallagher A, Home PD.
    Diabetes Res Clin Pract; 2005 Mar; 67(3):196-203. PubMed ID: 15713351
    [Abstract] [Full Text] [Related]

  • 3. Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents.
    Home PD, Pacini G.
    Diabetes Obes Metab; 2008 Sep; 10(9):699-718. PubMed ID: 17825080
    [Abstract] [Full Text] [Related]

  • 4. [Prandial glucose regulator for type 2 diabetic patients. Beta cells produce insulin according to need].
    MMW Fortschr Med; 1999 Sep 09; 141(36):61. PubMed ID: 10904606
    [No Abstract] [Full Text] [Related]

  • 5. Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes.
    Jacobson PB, von Geldern TW, Ohman L, Osterland M, Wang J, Zinker B, Wilcox D, Nguyen PT, Mika A, Fung S, Fey T, Goos-Nilsson A, Grynfarb M, Barkhem T, Marsh K, Beno DW, Nga-Nguyen B, Kym PR, Link JT, Tu N, Edgerton DS, Cherrington A, Efendic S, Lane BC, Opgenorth TJ.
    J Pharmacol Exp Ther; 2005 Jul 09; 314(1):191-200. PubMed ID: 15784656
    [Abstract] [Full Text] [Related]

  • 6. Improving post-prandial control with Humalog and Humalog mixtures.
    Lüddeke HJ.
    Int J Clin Pract Suppl; 2000 Sep 09; (112):23-8. PubMed ID: 11064948
    [No Abstract] [Full Text] [Related]

  • 7. Clinical significance of post-prandial blood glucose excursions in type 1 and type 2 diabetes mellitus.
    Slama G.
    Int J Clin Pract Suppl; 2000 Sep 09; (112):9-12. PubMed ID: 11064945
    [No Abstract] [Full Text] [Related]

  • 8. Importance of postprandial glucose control.
    Bell DS.
    South Med J; 2001 Aug 09; 94(8):804-9. PubMed ID: 11549192
    [Abstract] [Full Text] [Related]

  • 9. Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control.
    Robertson C.
    Diabetes Educ; 2006 Aug 09; 32(3):423-32. PubMed ID: 16772658
    [Abstract] [Full Text] [Related]

  • 10. Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis.
    Colombo M, Kruhoeffer M, Gregersen S, Agger A, Jeppesen P, Oerntoft T, Hermansen K.
    Metabolism; 2006 Jan 09; 55(1):43-52. PubMed ID: 16324918
    [Abstract] [Full Text] [Related]

  • 11. Hypoglycemic effect of hot-water extract of adzuki (Vigna angularis) in spontaneously diabetic KK-A(y) mice.
    Itoh T, Kobayashi M, Horio F, Furuichi Y.
    Nutrition; 2009 Feb 09; 25(2):134-41. PubMed ID: 18929464
    [Abstract] [Full Text] [Related]

  • 12. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A, Del Prato S, Bue-Valleskey J, Beattie S, Gates J, de la Peña A, Malone J.
    J Diabetes Complications; 2007 Feb 09; 21(1):20-7. PubMed ID: 17189870
    [Abstract] [Full Text] [Related]

  • 13. [Prandial regulation of glycemia].
    Metelko Z, Pavlić-Renar I, Novak B.
    Lijec Vjesn; 2002 Feb 09; 124(3-4):55-62. PubMed ID: 18956821
    [Abstract] [Full Text] [Related]

  • 14. [Fasting hyperglycemia and postprandial glucose peaks. Diabetes therapy mustact on 2 sides].
    MMW Fortschr Med; 2003 Aug 21; 145(33-34):59. PubMed ID: 14526583
    [No Abstract] [Full Text] [Related]

  • 15. [Biochemical viewpoint of the determination of the blood sugar decreasing and antidiabetic effect of sulfonylurea derivatives].
    Hasselblatt A.
    Internist (Berl); 1966 Aug 21; 7(8):369-74. PubMed ID: 4863410
    [No Abstract] [Full Text] [Related]

  • 16. Medicine. Drug deals diabetes a one-two punch.
    Couzin J.
    Science; 2003 Jul 18; 301(5631):290. PubMed ID: 12869732
    [No Abstract] [Full Text] [Related]

  • 17. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG, Jung DY, Ko HJ, Zhang Z, Ma Z, Jun JY, Kim JH, Sumner AD, Vary TC, Gardner TW, Bronson SK, Kim JK.
    Am J Physiol Endocrinol Metab; 2007 Dec 18; 293(6):E1687-96. PubMed ID: 17911348
    [Abstract] [Full Text] [Related]

  • 18. Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes.
    Phillips JW, Barringhaus KG, Sanders JM, Yang Z, Chen M, Hesselbacher S, Czarnik AC, Ley K, Nadler J, Sarembock IJ.
    Circulation; 2003 Oct 21; 108(16):1994-9. PubMed ID: 14517165
    [Abstract] [Full Text] [Related]

  • 19. Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes.
    Vakkilainen J, Mero N, Schweizer A, Foley JE, Taskinen MR.
    Diabetes Metab Res Rev; 2002 Oct 21; 18(6):484-90. PubMed ID: 12469362
    [Abstract] [Full Text] [Related]

  • 20. [Postprandial blood glucose as the driving force in pathogenesis of type 2 diabetes].
    Liebl A.
    Med Klin (Munich); 2003 Oct 15; 98 Suppl 1():7-11. PubMed ID: 14694835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.